Korbel Gregory Alan
SVP, Chief Business Officer at APRE
- Sold, on record
- $545k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 1, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- APREAprea Therapeutics, Inc.SVP, Chief Business Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale APREUnusualSep 20 2021
Sold 32,960 shares at $4.97 ($164k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 65.8% of holdings ($249k position)17,167 shares leftFirst sale on recordFiling
- 2 Form 4 sale APREUnusualOct 1 +11 days
Sold 27,500 shares at $4.89 ($134k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 61.6% of holdings ($218k position)17,167 shares leftFiling
- 3 Form 4 sale APREUnusualNov 1 +31 days
Sold 27,500 shares at $5.00 ($138k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 61.6% of holdings ($223k position)17,167 shares leftFiling
- 4 Form 4 sale APREUnusualDec 1 +30 days
Sold 27,500 shares at $3.96 ($109k)
Korbel Gregory Alan, SVP, Chief Business Officer
Sold 61.6% of holdings ($177k position)17,167 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | APRE | SVP, Chief Business Officer | Form 4 sale | 27,500 | $109k | 61.6% | Unusual | SEC |
| Nov 1, 2021 | APRE | SVP, Chief Business Officer | Form 4 sale | 27,500 | $138k | 61.6% | Unusual | SEC |
| Oct 1, 2021 | APRE | SVP, Chief Business Officer | Form 4 sale | 27,500 | $134k | 61.6% | Unusual | SEC |
| Sep 20, 2021 | APRE | SVP, Chief Business Officer | Form 4 sale | 32,960 | $164k | 65.8% | Unusual | SEC |